Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance

Background and Purpose: The effect of uric acid (UA) levels on severity and prognosis of spontaneous intracerebral hemorrhage (ICH) remains controversial. We aimed to explore the association of admission UA levels with stroke severity and outcomes in ICH patients.Materials and Methods: The patients...

Full description

Bibliographic Details
Main Authors: Xinmin Liu, Zhentang Cao, Hongqiu Gu, Kaixuan Yang, Ruijun Ji, Zixiao Li, Xingquan Zhao, Yongjun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.609938/full
_version_ 1818919550623678464
author Xinmin Liu
Xinmin Liu
Zhentang Cao
Zhentang Cao
Hongqiu Gu
Hongqiu Gu
Hongqiu Gu
Hongqiu Gu
Kaixuan Yang
Kaixuan Yang
Kaixuan Yang
Kaixuan Yang
Ruijun Ji
Ruijun Ji
Ruijun Ji
Ruijun Ji
Zixiao Li
Zixiao Li
Zixiao Li
Zixiao Li
Xingquan Zhao
Xingquan Zhao
Xingquan Zhao
Xingquan Zhao
Yongjun Wang
Yongjun Wang
Yongjun Wang
Yongjun Wang
author_facet Xinmin Liu
Xinmin Liu
Zhentang Cao
Zhentang Cao
Hongqiu Gu
Hongqiu Gu
Hongqiu Gu
Hongqiu Gu
Kaixuan Yang
Kaixuan Yang
Kaixuan Yang
Kaixuan Yang
Ruijun Ji
Ruijun Ji
Ruijun Ji
Ruijun Ji
Zixiao Li
Zixiao Li
Zixiao Li
Zixiao Li
Xingquan Zhao
Xingquan Zhao
Xingquan Zhao
Xingquan Zhao
Yongjun Wang
Yongjun Wang
Yongjun Wang
Yongjun Wang
author_sort Xinmin Liu
collection DOAJ
description Background and Purpose: The effect of uric acid (UA) levels on severity and prognosis of spontaneous intracerebral hemorrhage (ICH) remains controversial. We aimed to explore the association of admission UA levels with stroke severity and outcomes in ICH patients.Materials and Methods: The patients enrolled in this study were from the China Stroke Center Alliance study (CSCA). Patients were divided into four groups (Q1–Q4) according to the quartiles of UA levels at admission. The primary outcome was in-hospital mortality. The secondary outcomes included stroke severity, in-hospital complications, and discharge disposition. Multivariate logistic regression was adopted to explore the association of UA levels with outcomes after ICH.Results: Patients (84,304) with acute ICH were included in the final analysis; the median (interquartile range) of UA was 277 (210, 354) μmol/L. The four groups were defined as follows: Q1 ≤ 210 μmol/L, 210 μmol/L < Q2 ≤ 277 μmol/L, 277 μmol/L < Q3 ≤ 354 μmol/L, Q4 > 354 μmol/L. There was no significant evidence indicating that UA levels were correlated with the discharge disposition and in-hospital mortality after ICH. However, compared to Q1, the patients with higher UA levels had decreased odds of severe stroke (NIHSS ≥ 16) at admission (OR 0.89, 95% CI 0.86–0.92). An L-shaped association was found between UA and severe stroke. Among in-hospital complications, decrease in pneumonia, poor swallow function, gastrointestinal bleeding, and deep vein thrombosis (DVT) were significantly associated with higher UA levels compared to Q1 (P for trend < 0.0001).Conclusions: UA was a protective factor for stroke severity and in-hospital complications such as pneumonia, poor swallow function, gastrointestinal bleeding, and DVT. However, no significant evidence indicated that UA levels were predictive of the discharge disposition and in-hospital mortality after ICH.
first_indexed 2024-12-20T01:07:39Z
format Article
id doaj.art-766c9a84e9ad49dab60778e3cc1316e9
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-20T01:07:39Z
publishDate 2020-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-766c9a84e9ad49dab60778e3cc1316e92022-12-21T19:58:47ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-12-011110.3389/fneur.2020.609938609938Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center AllianceXinmin Liu0Xinmin Liu1Zhentang Cao2Zhentang Cao3Hongqiu Gu4Hongqiu Gu5Hongqiu Gu6Hongqiu Gu7Kaixuan Yang8Kaixuan Yang9Kaixuan Yang10Kaixuan Yang11Ruijun Ji12Ruijun Ji13Ruijun Ji14Ruijun Ji15Zixiao Li16Zixiao Li17Zixiao Li18Zixiao Li19Xingquan Zhao20Xingquan Zhao21Xingquan Zhao22Xingquan Zhao23Yongjun Wang24Yongjun Wang25Yongjun Wang26Yongjun Wang27Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, ChinaBackground and Purpose: The effect of uric acid (UA) levels on severity and prognosis of spontaneous intracerebral hemorrhage (ICH) remains controversial. We aimed to explore the association of admission UA levels with stroke severity and outcomes in ICH patients.Materials and Methods: The patients enrolled in this study were from the China Stroke Center Alliance study (CSCA). Patients were divided into four groups (Q1–Q4) according to the quartiles of UA levels at admission. The primary outcome was in-hospital mortality. The secondary outcomes included stroke severity, in-hospital complications, and discharge disposition. Multivariate logistic regression was adopted to explore the association of UA levels with outcomes after ICH.Results: Patients (84,304) with acute ICH were included in the final analysis; the median (interquartile range) of UA was 277 (210, 354) μmol/L. The four groups were defined as follows: Q1 ≤ 210 μmol/L, 210 μmol/L < Q2 ≤ 277 μmol/L, 277 μmol/L < Q3 ≤ 354 μmol/L, Q4 > 354 μmol/L. There was no significant evidence indicating that UA levels were correlated with the discharge disposition and in-hospital mortality after ICH. However, compared to Q1, the patients with higher UA levels had decreased odds of severe stroke (NIHSS ≥ 16) at admission (OR 0.89, 95% CI 0.86–0.92). An L-shaped association was found between UA and severe stroke. Among in-hospital complications, decrease in pneumonia, poor swallow function, gastrointestinal bleeding, and deep vein thrombosis (DVT) were significantly associated with higher UA levels compared to Q1 (P for trend < 0.0001).Conclusions: UA was a protective factor for stroke severity and in-hospital complications such as pneumonia, poor swallow function, gastrointestinal bleeding, and DVT. However, no significant evidence indicated that UA levels were predictive of the discharge disposition and in-hospital mortality after ICH.https://www.frontiersin.org/articles/10.3389/fneur.2020.609938/fulluric acidintracerebral hemorrhageseveritymortalitycomplication
spellingShingle Xinmin Liu
Xinmin Liu
Zhentang Cao
Zhentang Cao
Hongqiu Gu
Hongqiu Gu
Hongqiu Gu
Hongqiu Gu
Kaixuan Yang
Kaixuan Yang
Kaixuan Yang
Kaixuan Yang
Ruijun Ji
Ruijun Ji
Ruijun Ji
Ruijun Ji
Zixiao Li
Zixiao Li
Zixiao Li
Zixiao Li
Xingquan Zhao
Xingquan Zhao
Xingquan Zhao
Xingquan Zhao
Yongjun Wang
Yongjun Wang
Yongjun Wang
Yongjun Wang
Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance
Frontiers in Neurology
uric acid
intracerebral hemorrhage
severity
mortality
complication
title Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance
title_full Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance
title_fullStr Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance
title_full_unstemmed Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance
title_short Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance
title_sort uric acid and clinical outcomes among intracerebral hemorrhage patients results from the china stroke center alliance
topic uric acid
intracerebral hemorrhage
severity
mortality
complication
url https://www.frontiersin.org/articles/10.3389/fneur.2020.609938/full
work_keys_str_mv AT xinminliu uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT xinminliu uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT zhentangcao uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT zhentangcao uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT hongqiugu uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT hongqiugu uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT hongqiugu uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT hongqiugu uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT kaixuanyang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT kaixuanyang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT kaixuanyang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT kaixuanyang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT ruijunji uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT ruijunji uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT ruijunji uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT ruijunji uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT zixiaoli uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT zixiaoli uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT zixiaoli uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT zixiaoli uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT xingquanzhao uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT xingquanzhao uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT xingquanzhao uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT xingquanzhao uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT yongjunwang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT yongjunwang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT yongjunwang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance
AT yongjunwang uricacidandclinicaloutcomesamongintracerebralhemorrhagepatientsresultsfromthechinastrokecenteralliance